These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36843079)

  • 21. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant treatment for postnatal depression.
    Brown JVE; Wilson CA; Ayre K; Robertson L; South E; Molyneaux E; Trevillion K; Howard LM; Khalifeh H
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013560. PubMed ID: 33580709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociological influences on antidepressant prescribing.
    Sleath B; Shih YC
    Soc Sci Med; 2003 Mar; 56(6):1335-44. PubMed ID: 12600369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis.
    Breedvelt JJF; Warren FC; Segal Z; Kuyken W; Bockting CL
    JAMA Psychiatry; 2021 Aug; 78(8):868-875. PubMed ID: 34009273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
    Tallon D; Wiles N; Campbell J; Chew-Graham C; Dickens C; Macleod U; Peters TJ; Lewis G; Anderson IM; Gilbody S; Hollingworth W; Davies S; Kessler D
    Trials; 2016 Feb; 17():66. PubMed ID: 26842107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial.
    Wentink C; Huijbers MJ; Lucassen P; Kramers C; Akkermans R; Adang E; Spijker J; Speckens AEM
    BMC Fam Pract; 2019 Jul; 20(1):105. PubMed ID: 31349796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study.
    Ambresin G; Palmer V; Densley K; Dowrick C; Gilchrist G; Gunn JM
    J Affect Disord; 2015 May; 176():125-32. PubMed ID: 25704565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
    Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
    Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for treatment-resistant depression in adults.
    Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial.
    Kingslake J; Dias R; Dawson GR; Simon J; Goodwin GM; Harmer CJ; Morriss R; Brown S; Guo B; Dourish CT; Ruhé HG; Lever AG; Veltman DJ; van Schaik A; Deckert J; Reif A; Stäblein M; Menke A; Gorwood P; Voegeli G; Pérez V; Browning M
    Trials; 2017 Nov; 18(1):558. PubMed ID: 29169399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.
    Duffy L; Bacon F; Clarke CS; Donkor Y; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Lewis G; Mangin D; Marston L; Moore M; Nazareth I; Wiles N; Lewis G
    Trials; 2019 Jun; 20(1):319. PubMed ID: 31159856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial.
    Sharp DJ; Chew-Graham C; Tylee A; Lewis G; Howard L; Anderson I; Abel K; Turner KM; Hollinghurst SP; Tallon D; McCarthy A; Peters TJ
    Health Technol Assess; 2010 Sep; 14(43):iii-iv, ix-xi, 1-153. PubMed ID: 20860888
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.